VIMTA LABS
Back to Balance Sheet
|
VIMTA LABS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹104 Cr | ₹106 Cr | ₹77 Cr | ₹57 Cr | ₹38 Cr |
What is the latest Net Current Assets ratio of VIMTA LABS ?
| Year | Net Current Assets |
|---|---|
| Mar2024 | ₹104 Cr |
| Mar2023 | ₹106 Cr |
| Mar2022 | ₹77 Cr |
| Mar2021 | ₹57 Cr |
| Mar2020 | ₹38 Cr |
How is Net Current Assets of VIMTA LABS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2024 | ₹104 Cr | -2.68 | |
| Mar2023 | ₹106 Cr | 38.86 | |
| Mar2022 | ₹77 Cr | 35.29 | |
| Mar2021 | ₹57 Cr | 47.85 | |
| Mar2020 | ₹38 Cr | - | |
Compare Net Current Assets of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹2,364.5 Cr | -3.6% | -10.8% | 26.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,773.0 Cr | -6.8% | -7.6% | -4.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,540.0 Cr | -6.6% | -5.8% | 4.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,529.0 Cr | 0.9% | 5.7% | 27.3% | Stock Analytics | |
| CIPLA | ₹111,299.0 Cr | -4.8% | -8.1% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,393.0 Cr | -2% | -8.8% | -12.9% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | -3.6% |
-10.8% |
26.6% |
| SENSEX | -2% |
-2.8% |
7.4% |
You may also like the below Video Courses